About 300 reports

Global Coronavirus COVID ## Clinical Trials Insight 2020 ##.

  • Clinical Trial
  • Drug Development
  • Pharmaceutical
  • Therapy
  • World

APPENDIX ##. ## DISCUSSION GUIDE Q. ##.

  • Drug Development
  • North America
  • United States
  • Market Size
  • Supply
  • Cystic Fibrosis Drug Pipeline by Anti-Infective Class
  • Cystic Fibrosis Drug Pipeline by Anti-Infective Class

Table ##. ## Cystic Fibrosis Drug Pipeline by Anti-Infective Class The drugs in the anti-infective class are primarily antibiotics, followed by antibacterials and antimicrobials.

  • Cystic Fibrosis
  • Drug Development
  • World
  • AbbVie Inc.
  • Vertex Pharmaceuticals Incorporated

The details ##.

  • Drug Development
  • World
  • Forecast
  • Market Size
  • Supply
  • 14.10 TRILOGY WRITING AND CONSULTING GMBH 14.10.1 KEY FACTS
  • THREATS

Table ##.

  • Drug Development
  • United States
  • World
  • Forecast
  • PAREXEL International Corporation
  • 11.7 MEDPACE 11.7.1 KEY FACTS

THE COMPANY FOCUSES ON CONDUCTING CLINICAL TRIALS ACROSS ALL MAJOR THERAPEUTIC AREAS NAMELY, CARDIOLOGY, METABOLIC DISEASE, ONCOLOGY, ENDOCRINOLOGY, CENTRAL NERVOUS SYSTEM, OR CNS, ANTIVIRAL AND ANTI-INFECTIVE, AS WELL AS THERAPEUTIC EXPERTISE IN MEDICAL DEVICES.

  • Drug Development
  • Forecast
  • Market Size
  • Charles River Laboratories International, Inc.
  • Covance Inc.
  • 13.8 MEDPACE

Table ##.

  • Drug Development
  • North America
  • World
  • Forecast
  • PAREXEL International Corporation

Drug Discovery Outsourcing Market Analysis Report By Workflow, By Therapeutic Area, By Drug Type And Segment Forecasts, 2018 - 2025 Chapter ## Research Methodology ##. ## Information Procurement ##. ## Data Analysis Chapter ## Executive Summary ##. ## Market Snapshot Chapter ## Drug Discovery Outsourci

  • Drug Development
  • United States
  • Forecast

Previously, in her role as Principal Oncology Analyst at Sociable Pharma, she was responsible for managing the product development and delivery of research & analysis content for hematology and immuno-oncology services, and has also managed Sociable Pharma' s Respiratory and Anti-

  • Drug Development
  • United States
  • Eli Lilly & Co.
  • MedImmune, LLC
  • Merck & Co., Inc.

Phase ## and Phase ##, then phase ## WHICH ONE IS THE FASTEST GROWING?

  • Drug Development
  • World
  • Forecast
  • Market Size
  • Supply
  • 7. MARKET SEGMENTATION
  • 9.2.4 LSK GLOBAL PHARMA SERVICE CO. LTD - SWOT ANALYSIS

THE COMPANY OFFERS APIS IN THE CARDIOVASCULAR SYSTEM, CENTRAL NERVOUS SYSTEM, AND ANTI-INFECTIVE THERAPEUTIC AREAS; AND DEVELOPS DOSAGE FORMS, INCLUDING ORAL SOLID, INJECTABLE, AND OPHTHALMIC DOSAGE FORMS.

  • Drug Development
  • Catalent Pharma Solutions, Inc.
  • Lonza Group Ltd
  • Pfizer Inc.
  • Recipharm Group

THE SEGMENT INCLUDES ANTI-INFECTIVES AND BIOSIMILARS.

  • Drug Development
  • World
  • Forecast
  • Allergan plc
  • Galderma S.A.
  • 14.10 MEDPACE
  • THREATS

TABLE ##.

  • Drug Development
  • World
  • Forecast
  • Market Size
  • Charles River Laboratories International, Inc.

Phase ## and Phase ##, then phase ## WHICH ONE IS THE FASTEST GROWING?

  • Drug Development
  • World
  • Forecast
  • Market Size
  • Supply
  • OTHER PROMINENT VENDORS

Its formulations are used for therapeutic areas of the central nervous system (CNS), gastrointestinal, anti-infectives, asthma, pediatrics, cardiovascular, diabetology, and nonsteroidal antiinflammatory drug therapy.

  • Drug Development
  • World
  • Forecast
  • Charles River Laboratories International, Inc.
  • Evotec AG

Anti-inflammatory agents, antiviral agents, immunomodulatory agents, ophthalmic agents, ophthalmogical anti-infectives and even dermatological agents are being tested in order to fulfill the existing unmet need and standardize a proper treatment regime for all types of uveitis.

  • Drug Development
  • Forecast
  • Market Size
  • Allergan plc
  • Clearside Biomedical, Inc.

THE COMPANY HAS PARTNERSHIP WITH SMALL AND LARGE BIOPHARMACEUTICAL COMPANIES TO DEVELOP THERAPIES IN ANTI-INFECTIVE, CRITICAL INFECTIOUS DISEASE AND ONCOLOGY AREAS.

  • Drug Development
  • Latin America
  • Mexico
  • North America
  • Forecast

First and subsequent-cycle administration of Neulasta resulted in a ## percent reduction in the incidence of febrile neutropenia (## percent versus ## percent with placebo), a ## percent reduction in the incidence of hospitalization (## percent versus ## percent with placebo) and an

  • Drug Development
  • United States
  • Amgen Inc.
  • Kyowa Hakko Kirin Co., Ltd.
  • Neupogen group

THE COMPANY HAS PARTNERSHIP WITH SMALL AND LARGE BIOPHARMACEUTICAL COMPANIES TO DEVELOP THERAPIES IN ANTI-INFECTIVE, CRITICAL INFECTIOUS DISEASE AND ONCOLOGY AREAS.

  • Drug Development
  • Eastern Europe
  • Russia
  • Forecast
  • bioMerieux S.A.

Anti-infective skin preparations such as Fucidin (fusidic acid, an antibacterial agent) or Canesten (clotrimazole, an antifungal agent) may be used when a pathogenic infection is suspected, either alone or as a combination therapy with topical corticosteroids.

  • Drug Development
  • AbbVie Inc.
  • Allergan plc
  • Amgen Inc.
  • Apricus Biosciences, Inc.

Antibiotics belong to the antimicrobial class of drugs, a broad category that also contains anti-virals, anti-fungal and anti-parasitic drugs.

  • Antibiotic Resistance
  • Drug Development
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Pfizer Inc.
  • 6.2.3.4. CADD SERVICE PORTFOLIO

THE COMPANY COLLABORATED WITH SANOFI TO IN-LICENSE THE MAJORITY OF DRUGS UNDER SANOFI' S ANTI-INFECTIVES RESEARCH AND DEVELOPMENT PIPELINE.

  • Drug Development
  • United States
  • World
  • BioNTech AG.
  • Evotec AG

ABBOTT MAINLY FOCUSES ON SIX CORE THERAPEUTIC AREAS SUCH AS GASTROENTEROLOGY, WOMEN' S HEALTH, CARDIO-METABOLIC, PAIN/ CENTRAL NERVOUS SYSTEM, RESPIRATORY ANTI-INFECTIVES, AND INFLUENZA VACCINE.

  • Drug Development
  • World
  • Market Size
  • Agilent Technologies, Inc.
  • Danaher Corporation

In therapeutics segment, company produces over 2000 high quality molecules that includes psychiatry, Ticker Symbol : NSE:SUNPHARMA anti-infectives, neurology, cardiology, orthopaedic, diabetology, Industry : Pharmaceutical gastroenterology, ophthalmology, nephrology, urology, derma

  • Drug Development
  • Therapy
  • Boehringer Ingelheim GmbH
  • Sun Pharmaceutical Industries Limited
  • Valeant Pharmaceuticals International, Inc.
  • ANGIOTECH PHARMACEUTICALS INC PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • Hemodialysis Catheters Companies and Product Overview

In some jurisdictions, Fresenius failed to take basic steps such as providing anti-corruption training or performing due diligence on its agents.

  • Catheter
  • Drug Development
  • United States
  • Company Financials
  • Fresenius Group
  • ANTI-INFECTIVE ENDOTRACHEAL TUBE - PRODUCT DESCRIPTION
  • ANTI-INFECTIVE ENDOTRACHEAL TUBE - PRODUCT STATUS

ANTI-INFECTIVE ENDOTRACHEAL TUBE PRODUCT OVERVIEW TABLE ##: ANTI-INFECTIVE ENDOTRACHEAL TUBE - PRODUCT STATUS Baylor College of Medicine (BCM) is a health science university that offers educational services.

  • Drug Development
  • United States
  • Company
  • Company Financials
  • Medtronic, Inc.

ANTI-DRUG ANTIBODIES WERE OBSERVED IN ONLY ONE PATIENT, INDICATING A LOW IMMUNOGENIC POTENTIAL OF MP##.

  • Drug Development
  • United States
  • Allergan plc
  • Molecular Partners AG
  • Roche Group
  • ANTI-INFECTIVE ENDOTRACHEAL TUBE - PRODUCT DESCRIPTION
  • ANTI-INFECTIVE ENDOTRACHEAL TUBE - PRODUCT STATUS

One unit refers to one intubation bougie.

  • Clinical Trial
  • Drug Development
  • United States
  • Company
  • Medtronic, Inc.
  • VINDICA THERAPEUTICS, INC PIPELINE PRODUCTS & ONGOING CLINICAL TRIALS OVERVIEW
  • Central Venous Catheters Companies and Product Overview

ANTI-THROMBOTIC AND ANTI-INFECTIVE CENTRAL VENOUS CATHETER PRODUCT OVERVIEW TABLE ##: ANTI-THROMBOTIC AND ANTI-INFECTIVE CENTRAL VENOUS CATHETER - PRODUCT STATUS TABLE ##: ANTI-THROMBOTIC AND ANTI-INFECTIVE CENTRAL VENO

  • Drug Development
  • Hospital
  • United States
  • Company
  • Teleflex Incorporated
  • FU ANTI-INFECTIVE HEMOSTREAM DIALYSIS CATHETER - PRODUCT DESCRIPTION
  • FU ANTI-INFECTIVE HEMOSTREAM DIALYSIS CATHETER - PRODUCT STATUS

The CE Mark approval means that ExThera' s Seraph ## meets the safety and performance requirements for medical devices in the European Economic Area (EEA) as an adjunct to anti-infective therapy.

  • Clinical Trial
  • Drug Development
  • Medical Device
  • United States
  • Fresenius Group